91 related articles for article (PubMed ID: 32767239)
21. The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line.
Wolfesberger B; Tonar Z; Gerner W; Skalicky M; Heiduschka G; Egerbacher M; Thalhammer JG; Walter I
Res Vet Sci; 2010 Feb; 88(1):94-100. PubMed ID: 19665156
[TBL] [Abstract][Full Text] [Related]
22. Elevated expression of matrix metalloproteinase-3 in human osteosarcoma and its association with tumor metastasis.
Huang JF; Du WX; Chen JJ
J BUON; 2016; 21(1):235-43. PubMed ID: 27061553
[TBL] [Abstract][Full Text] [Related]
23. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics.
Haake SM; Li J; Bai Y; Kinose F; Fang B; Welsh EA; Zent R; Dhillon J; Pow-Sang JM; Chen YA; Koomen JM; Rathmell WK; Fishman M; Haura EB
Clin Cancer Res; 2016 Nov; 22(22):5605-5616. PubMed ID: 27220961
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases.
Sun L; Tran N; Tang F; App H; Hirth P; McMahon G; Tang C
J Med Chem; 1998 Jul; 41(14):2588-603. PubMed ID: 9651163
[TBL] [Abstract][Full Text] [Related]
26. Src nuclear localization and its prognostic relevance in human osteosarcoma.
Urciuoli E; Coletta I; Rizzuto E; De Vito R; Petrini S; D'Oria V; Pezzullo M; Milano GM; Cozza R; Locatelli F; Peruzzi B
J Cell Physiol; 2018 Feb; 233(2):1658-1670. PubMed ID: 28671269
[TBL] [Abstract][Full Text] [Related]
27. P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K/AKT/mTOR pathway.
Song R; Tian K; Wang W; Wang L
Int J Surg; 2015 Aug; 20():80-7. PubMed ID: 25936826
[TBL] [Abstract][Full Text] [Related]
28. Alkaline phosphatase measurements of paired normal and osteosarcoma tissue culture lines obtained from the same patient.
Thorpe W; Loeb W; Hyatt C; Rosenberg SA
Cancer Res; 1979 Jan; 39(1):277-9. PubMed ID: 282939
[TBL] [Abstract][Full Text] [Related]
29. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.
Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M
Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490
[TBL] [Abstract][Full Text] [Related]
30. Receptor tyrosine kinases in PI3K signaling: The therapeutic targets in cancer.
Jiang W; Ji M
Semin Cancer Biol; 2019 Dec; 59():3-22. PubMed ID: 30943434
[TBL] [Abstract][Full Text] [Related]
31. Involvement of extracellular signal-regulated kinase activation in human osteosarcoma cell resistance to the histone deacetylase inhibitor FK228 [(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-bis(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone].
Matsubara H; Watanabe M; Imai T; Yui Y; Mizushima Y; Hiraumi Y; Kamitsuji Y; Watanabe K; Nishijo K; Toguchida J; Nakahata T; Adachi S
J Pharmacol Exp Ther; 2009 Mar; 328(3):839-48. PubMed ID: 19073909
[TBL] [Abstract][Full Text] [Related]
32. Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis.
Sévère N; Dieudonné FX; Marty C; Modrowski D; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
J Bone Miner Res; 2012 Oct; 27(10):2108-17. PubMed ID: 22623369
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2.
Wang W; Zhou X; Wei M
Oncotarget; 2015 Apr; 6(12):10297-308. PubMed ID: 25912304
[TBL] [Abstract][Full Text] [Related]
34. Cathepsins and osteosarcoma: Expression analysis identifies cathepsin K as an indicator of metastasis.
Husmann K; Muff R; Bolander ME; Sarkar G; Born W; Fuchs B
Mol Carcinog; 2008 Jan; 47(1):66-73. PubMed ID: 17683065
[TBL] [Abstract][Full Text] [Related]
35. Focal adhesion kinase overexpression and its impact on human osteosarcoma.
Ren K; Lu X; Yao N; Chen Y; Yang A; Chen H; Zhang J; Wu S; Shi X; Wang C; Sun X
Oncotarget; 2015 Oct; 6(31):31085-103. PubMed ID: 26393679
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
[TBL] [Abstract][Full Text] [Related]
37. Structurally related class I and class II receptor protein tyrosine kinases are down-regulated by the same E3 protein coded for by human group C adenoviruses.
Kuivinen E; Hoffman BL; Hoffman PA; Carlin CR
J Cell Biol; 1993 Mar; 120(5):1271-9. PubMed ID: 8094718
[TBL] [Abstract][Full Text] [Related]
38. Increased Fas expression reduces the metastatic potential of human osteosarcoma cells.
Lafleur EA; Koshkina NV; Stewart J; Jia SF; Worth LL; Duan X; Kleinerman ES
Clin Cancer Res; 2004 Dec; 10(23):8114-9. PubMed ID: 15585647
[TBL] [Abstract][Full Text] [Related]
39. Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer.
Spanheimer PM; Lorenzen AW; De Andrade JP; Kulak MV; Carr JC; Woodfield GW; Sugg SL; Weigel RJ
Ann Surg Oncol; 2015 Dec; 22(13):4287-94. PubMed ID: 25971960
[TBL] [Abstract][Full Text] [Related]
40. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against osteosarcoma.
Zhu YR; Min H; Fang JF; Zhou F; Deng XW; Zhang YQ
Cancer Biol Ther; 2015; 16(4):602-9. PubMed ID: 25869769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]